Medicure MCUJF
OTC MCUJF
$2.05 +0.03 (+1.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

Medicure (MCUJF) Return on Capital Employed [ROCE] (2009 - 2026)

Updated

Medicure (MCUJF) reported Return on Capital Employed [ROCE] of 130.66% for the quarter ended Jun 30, 2026, up 95.46 percentage points from 35.20% a year earlier and up 8.35 percentage points from the prior quarter.

Analysis

Medicure (MCUJF) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Medicure posted Return on Capital Employed [ROCE] of 8.03%, down 16.66 percentage points from the prior year.

  • Return on Capital Employed [ROCE] has declined for three consecutive years, though with a five-year change of +45.09 percentage points (years ended Dec 2020 to Dec 2025).
  • By year, Return on Capital Employed [ROCE] came in at 24.70% in the year ended Dec 31, 2024 (-1.60 pp), 26.30% in the year ended Dec 31, 2023 (-11.93 pp), 38.23% in the year ended Dec 31, 2022 (+47.91 pp) and -9.68% in the year ended Dec 31, 2021 (+27.37 pp).
  • The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Return on Capital Employed [ROCE] since the quarter ended Jun 30, 2015.
  • Year over year, Return on Capital Employed [ROCE] has now increased in each of the last four quarters, with an average year-over-year change of +28.60 percentage points over the last seven quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was the quarter ended Jun 30, 2026 (a gain of 95.46 percentage points); the low point was the quarter ended Mar 31, 2024 (a drop of 35.15 percentage points).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at 122.31% (quarter ended Mar 31, 2026), 85.54% (quarter ended Dec 31, 2025) and 58.20% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Medicure 210.81 Mn 202.62 Mn 2.31 Mn 130.66%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 130.66%
Mar 31, 2026 122.31%
Dec 31, 2025 85.54%
Sep 30, 2025 58.20%
Jun 30, 2025 35.20%
Mar 31, 2025 31.16%
Dec 31, 2024 34.92%
Sep 30, 2024 43.73%
Jun 30, 2024 40.64%
Mar 31, 2024 46.89%
Dec 31, 2023 65.24%
Mar 31, 2023 82.04%
Dec 31, 2022 66.54%
Sep 30, 2022 33.41%
Jun 30, 2022 6.18%
Mar 31, 2022 5.62%
Dec 31, 2021 -4.56%
Sep 30, 2021 -9.83%
Jun 30, 2021 -9.13%
Mar 31, 2021 -7.67%
API Access

Medicure Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MCUJF&period=max&api_key=YOUR_API_KEY